Protective Efficacy of a Toxoplasma gondii Rhoptry Protein 13 Plasmid DNA Vaccine in Mice
- 1 December 2012
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 19 (12) , 1916-1920
Abstract
Toxoplasma gondiiis an obligate intracellular parasite infecting humans and other warm-blooded animals, resulting in serious public health problems and economic losses worldwide. Rhoptries are involved inT. gondiiinvasion and host cell interaction and have been implicated as important virulence factors. In the present study, a DNA vaccine expressing rhoptry protein 13 (ROP13) ofT. gondiiinserted into eukaryotic expression vector pVAX I was constructed, and the immune protection it induced in Kunming mice was evaluated. Kunming mice were immunized intramuscularly with pVAX-ROP13 and/or with interleukin-18 (IL-18). Then, we evaluated the immune response using a lymphoproliferative assay, cytokine and antibody measurements, and the survival times of mice challenged with the virulentT. gondiiRH strain (type I) and the cyst-forming PRU strain (type II). The results showed that pVAX-ROP13 alone or with pVAX/IL-18 induced a high level of specific anti-T. gondiiantibodies and specific lymphocyte proliferative responses. Coinjection of pVAX/IL-18 significantly increased the production of gamma interferon (IFN-γ), IL-2, IL-4, and IL-10. Further, challenge experiments showed that coimmunization of pVAX-ROP13 with pVAX/IL-18 significantly (P< 0.05) increased survival time (32.3 ± 2.7 days) compared with pVAX-ROP13 alone (24.9 ± 2.3 days). Immunized mice challenged withT. gondiicysts (strain PRU) had a significant reduction in the number of brain cysts, suggesting that ROP13 could trigger a strong humoral and cellular response againstT. gondiicyst infection and that it is a potential vaccine candidate against toxoplasmosis, which provided the foundation for further development of effective vaccines againstT. gondii.Keywords
This publication has 26 references indexed in Scilit:
- Protective Immunity Induced by Toxoplasma gondii Rhoptry Protein 16 against Toxoplasmosis in MiceClinical and Vaccine Immunology, 2011
- The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18Research in Veterinary Science, 2010
- Processing and secretion of ROP13: A unique Toxoplasma effector proteinInternational Journal for Parasitology, 2010
- An enhanced GRA1–GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigsVaccine, 2008
- Vaccination as a control strategy against the coccidial parasitesEimeria,ToxoplasmaandNeosporaParasitology, 2006
- Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondiiMicrobes and Infection, 2006
- Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccineVaccine, 2006
- The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infectionMicrobes and Infection, 2004
- Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in catsParasitology Research, 2002
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995